Search for Clinical Trial Results

Sponsored By

Pustular Psoriasis - 17 Studies Found

Status Study
Completed Study Name: A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Condition:
  • Generalized Pustular Psoriasis
  • Erythrodermic Psoriasis
    • Date: 2017-01-13
    Interventions: Drug: risankizumab risankizumab administered by subcutaneous injection.
Completed Study Name: Immune Signature of Palmoplantar Pustulosis
Condition: Palmoplantar Pustulosis
Date: 2013-01-29
Completed Study Name: An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
Condition: Palmoplantar Pustulosis
Date: 2015-12-14
Interventions:
  • Drug: Guselkumab Participants

Active, not recruiting Study Name: Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
Condition:
  • Generalized Pustular Psoriasis (GPP)
  • Adalimumab
  • Date: 2015-08-20
    Interventions: Drug: Adalimumab Adalimumab
Terminated Study Name: Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
Condition:
  • Palmo-Plantar Pustular Psoriasis
  • Palmo-Plantar Pustulosis

    • Date: 2010-03-18
    Interventions:
    • Drug: Ustekinumab Patients ran
Completed Study Name: Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
Condition: Psoriasis
Date: 2013-09-24
Interventions: Biological: Secukinumab Secukinumab 150 mg, provided in a 1 mL prefilled syringe (one syringe for 150 mg
Active, not recruiting Study Name: An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Condition: Pustular Psoriasis
Date: 2015-01-16
Interventions: Drug: Guselkumab Participants will receive 50 milligram (mg) guselkumab subcutaneously at Weeks 0, 4 and
Completed Study Name: BI655130 Single Dose in Generalized Pustular Psoriasis
Condition: Psoriasis
Date: 2016-11-29
Interventions: Drug: BI655130
Completed Study Name: A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
Condition: Palmoplantaris Pustulosis
Date: 2006-07-14
Interventions:
  • Drug: Placebo comparator Patie
Completed Study Name: A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
Condition:
  • Moderate to Severe Psoriasis
  • Generalized Pustular Psoriasis and
    Date: 2017-02-09
    Interventions:
    • Other: Placebo

Next >>>